K+ channel openers protect hippocampal neurons against oxidative injury and amyloid β-peptide toxicity

Brain Research

Volumn 706, Issue 2, 1996, Pages 328-332

  Goodman, Yadong ^a   Mattson, Mark P ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Alzheimer's disease; Diazoxide; Dichlorofluorescin; Hydrogen peroxide; Levochromakalim; Pinacidil

Indexed keywords

4 AMINOPYRIDINE; AMYLOID BETA PROTEIN; CROMAKALIM; DIAZOXIDE; FERROUS SULFATE; GLIBENCLAMIDE; PEROXIDE; PINACIDIL; POTASSIUM CHANNEL;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; EMBRYO; HIPPOCAMPUS; NERVE CELL; NERVE DEGENERATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

EID: 0030050677     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(95)01367-9     Document Type: Article

References (33)

1. Abele, A. and Miller, R., Potassium channel activators abolish excitotoxicity in cultured hippocampal pyramidal neurons, Neurosci. Lett., 115 (1990) 195-200.
2. Alarcon, S., Hernandez, J. and Laorden, M.L., Diazoxide blocks the morphine induced lengthening of action potential duration on guinea-pig papillary muscle, Gen. Pharmacol., 26 (1995) 589-592.
3. Barger, S.W., Fiscus, R.R., Ruth, P., Hofmann, F. and Mattson, M.P., Role of cyclic GMP in the regulation of neuronal calcium and survival by secreted forms of β amyloid precursor, J. Neurochem., 64 (1995) 2087-2096.
4. Beal, M., Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? Ann. Neurol., 31 (1992) 119-130.
5. Behl, C., Davis, J., Lesley, R. and Schubert, D., Hydrogen peroxide mediates amyloid B protein toxicity, Cell, 77 (1994) 817-827.
6. Benzi, G. and Moretti, A., Age-and peroxidative stress-related modifications of the cerebral enzymatic activities linked to mitochondria and the glutathione system, Free Rad. Biol. Med., 19 (1995) 77-101.
7. Bertolino, M., Baraldi, M., Parenti, C., Braghiroli, D., DiBella, M., Vicini, S. and Costa, E., Modulation of AMPA/kainate receptors by analogues of diazoxide and cyclothiazide in thin slices of rat hippocampus, Receptors Channels, 1 (1993) 267-278.
8. + channel opener diazoxide enhances glutamatergic currents and reduces GABAergic currents in hippocampal neurons, J. Neurophysiol., 69 (1993) 494-503.
9. Erdemli, G. and Krnjevic, K., Diazoxide suppresses slowly-in-activating outward and inward currents in CA1 hippocampal neurones, NeuroReport, 5 (1993) 249-251.
10. + channels and suppression of neuronal activity by secreted β-amyloid precursor protein, Nature, in press.
11. Goodman, Y. and Mattson, M.P., Secreted forms of β-amyloid precursor protein protect hippocampal neurons against amyloid β-peptide-induce oxidative injury, Exp. Neurol., 128 (1994) 1-12.
12. Goodman, Y., Steiner, M.R., Steiner, S.M. and Mattson, M.P., Nordihydroguaiaretic acid protects hippocampal neurons against amyloid β-peptide toxicity and attenuates free radical and calcium accumulation, Brain Res., 654 (1994) 171-176.
13. Grover, G.J., McCullough, J.R., D'Alonzo, A.J., Sargent, C.A. and Atwal, K.S., Cardioprotective profile of the cardiac-selective ATP-sensitive potassium channel opener BMS-180448, J. Cardiovasc. Pharmacol., 25 (1995) 40-50.
14. Hensley, K., Carney, J.M., Mattson, M.P., Aksenova, M., Harris, M., Wu, J.F., Floyd, R. and Butterfield, D.A., A model for β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer's disease, Proc. Natl. Acad. Sci. USA, 91 (1994) 3270-3274.
15. Lafon-Cazal, M., Pietri, S., Culcasi, M. and Bockaert, J., NMDA-dependent superoxide production and neurotoxicity, Nature, 364 (1993) 535-537.
16. Le, W.-D., Colom, L.V., Xie, W.-J, Smith, R.G., Alexianu, M. and Appel, S.H., Cell death induced by β-amyloid(1-40) in MES 23.5 hybrid clone: the role of nitric oxide and NMDA-gated channel activation leading to apoptosis, Brain Res., 686 (1995) 49-60.
17. Mark, R.J., Ashford, J.W. and Mattson, M.P., Anticonvulsants attenuate amyloid β-peptide neurotoxicity and promote maintenance of calcium homeostasis, Neurobiol. Aging, 16 (1994) 187-198.
18. 2+ homeostasis and cell death, J. Neurosci., 15 (1995) 6239-6249.
19. Mattson, M.P., Cheng, B., Davis, D., Bryant, K., Lieberburg, I. and Rydel, R.E., β-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity, J. Neurosci., 12 (1992) 376-389.
20. Mattson, M.P., Tomaselli, K. and Rydel, R.E., Calcium-destabilizing and neurodegenerative effects of aggregated β-amyloid peptide are attenuated by basic FGF, Brain Res., 621 (1993) 35-49.
21. Mattson, M.P., Barger, S.W., Begley, J.G. and Mark, R.J., Calcium, free radicals and excitotoxic neuronal death in primary cell culture, Methods Cell Biol., 46 (1995) 187-216.
22. i and neurotoxicity and increase antioxidant enzyme activities in hippocampal neurons, J. Neurochem., 65 (1995) 1740-1751.
23. McPherson, C.D., Pierce, G.N. and Cole, W.C., Ischemic cardioprotection by ATP-sensitive K+ channels involves high-energy phosphate preservation, Am. J. Physiol., 265 (1993) H1809-H1818.
24. + channel openers on interferon-γ-dependent immune response in experimental allergic neuritis (EAN), Autoimmunity, 18 (1994) 233-241.
25. Pike, C., Burdick, D., Walencewicz, A., Glabe, C. and Cotman, C., Neurodegeneration induced by β-amyloid peptides in vitro: the role of peptide assembly state, J. Neurosci., 13 (1993) 1676-1686.
26. Quast, U., Potassium channel openers: pharmacological and clinical aspects, Fund. Clin. Pharmacol., 6 (1992) 279-293.
27. Selkoe, D.J., Physiological production of the β-amyloid protein and the mechanism of Alzheimer's disease, Trends Neurosci., 16 (1993) 403-408.
28. Smith, C.D., Carney, J.M., Starke-Reed, P.E., Oliver, C.N., Stadtman, E.R., Floyd, R.A. and Markesbery, W.R., Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease, Proc. Natl. Acad. Sci. USA, 88 (1991) 10540-10543.
29. Toombs, C.F., Norman, N.R., Groppi, V.E., Lee, K.S., Gadwood, R.C. and Shebuski, R.J., Limitation of myocardial injury with the potassium channel opener cromakalim and the non-vasoactive analog U-89,232: vascular vs. cardiac actions in vitro and in vivo, J. Pharmacol. Exp. Ther., 263 (1992) 1261-1268.
30. Watson, B.D. and Ginsberg, M.D., Ischemic injury in the brain. Role of oxygen radical-mediated processes, Ann. NY Acad. Sci., 559 (1989) 269-281.
31. 2+ channel blockers attenuate beta-amyloid peptide toxicity to cortical neurons in culture, J. Neurochem., 62 (1994) 372-375.
32. Yankner, B.A., Duffy, L.K. and Kirschner, D.A., Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides, Science, 250 (1990) 279-282.
33. Zhang, Y., Tatsuno, T., Carney, J. and Mattson, M.P., Basic FGF, NGF and IGFs protect hippocampal neurons against iron-induced degeneration, J. Cerebral Blood Flow Metab., 13 (1993) 378-388.